DETROIT, MI
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)EICOSANOID RESEARCH FOUNDATION C/O KRISHNARAO MADDIPATI, founded in 2004, is a micro nonprofit in the Medical Research sector that reported $20K in total revenue in fiscal year 2023. Revenue fell 92% from the prior year — a significant decline worth monitoring. Expenses of $26K exceeded revenue, resulting in a 32% operating deficit.
THE PRIMARY EXEMPT PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO PROVIDE A FORUM FOR THE DISSEMINATION OF THE LATEST SCIENTIFIC INFORMATION ON BIOACTIVE LIPIDS IN HEALTH AND DISEASE AS IT RELATES TO CANCER, INFLAMATION AND INFLAMATION INDUCED DISEASES SUCH AS CARDIOVASCULAR, DIABETES, PSORIASIS AND ALZHEIMER'S. THIS PURPOSE IS ACCOMPLISHED THROUGH THE ORGANIZATION'S BIENNIAL CONFERENCE. THE EICOSANOID RESEARCH FOUNDATION SPONSORS BIENNIAL CONFERENCES HIGHLIGHTING DATA AT THE CUTTING EDGE OF MEDICAL SCIENCE. DURING THESE CONFERENCES NEW DRUGS AND MEDICATIONS ARE DISCUSSED, DATA ON CLINICAL TRIALS IS EXAMINED AND SCIENTISTS FROM ALL OVER THE WORLD INTERACT TO ENHANCE THEIR COLLABORATIVE RESEARCH EFFORTS. THE GOAL OF THIS MEETING SERIES IS TO PROMOTE THE EXCHANGE OF INFORMATION AND IDEAS AMONG INTERNATIONAL SCIENTISTS OF DIVERSE BACKGROUNDS. THE MAIN PURPOSE OF THE EICOSANOID RESEARCH FOUNDATION IS TO RAISE FUNDS TO SPONSOR THE INTERNATIONAL CONFERENCE ON BIOACTIVE LIPIDS IN CANCER,
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $20,080 | $265,748 | -0.9% |
| Expenses | $26,426 | $332,097 | -0.9% |
| Net Income | $-6,346 | $-66,349 | -0.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| CHARLES SERHAN | PRESIDENT | N/A |
Officer
|
$0 | $0 | $0 |
| KRISHNARAO MADDIPATI | TREASURER | N/A |
Director
|
$0 | $0 | $0 |
| MAKOTO ARITA | DIRECTOR | N/A |
Director
|
$0 | $0 | $0 |
| EDWARD DENNIS | DIRECTOR | N/A |
Director
|
$0 | $0 | $0 |
| GABOR TIGYI | DIRECTOR | N/A |
Director
|
$0 | $0 | $0 |
| TAKEHIKO YOKOMIZO | DIRECTOR | N/A |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2023 | $20,080 | $26,426 | $10,801 | $-6,346 |
| 2022 | $265,748 | $332,097 | $17,889 | $-66,349 |
| 2019 | $261,031 | $226,279 | $77,621 | $34,752 |
Compare EICOSANOID RESEARCH FOUNDATION C/O KRISHNARAO MADDIPATI with other nonprofits in Michigan and across the country.